3,4-Dimethylhippurate is an organic acid and a primary urinary metabolite formed from the metabolism of 1,2,4-trimethylbenzene (1,2,4-TMB). This compound is used as a biomarker to monitor occupational exposure to 1,2,4-TMB, particularly in workers exposed to its vapors.
High exposure concentrations of 1,2,4-TMB enhance the metabolic pathway leading to 3,4-dimethylhippurate formation due to the saturation of other detoxification pathways.
This metabolite provides insights into exposure levels and potential health risks associated with 1,2,4-TMB, which is commonly found in petroleum refining, motor vehicle exhaust, and various industrial processes.
3,4-Dimethylhippurate is an organic acid and a major urinary metabolite formed from the metabolism of 1,2,4-trimethylbenzene (1,2,4-TMB), an isomer of the trimethylbenzene (TMB) compounds.
The urinary excretion of 3,4-dimethylhippurate accounts for approximately 30.2% of the 1,2,4-TMB dose excreted in rats. [7.] It is used as a biomarker to monitor occupational exposure to 1,2,4-TMB vapor in workers. [8.]
At higher exposure concentrations of 1,2,4-TMB, the metabolic pathway leading to 3,4-dimethylhippurate formation becomes more significant due to the saturation of other detoxification pathways. [10., 11.]
The main exposure sources of trimethylbenzene (TMB) isomers include: [1., 2., 3., 5.]
Symptoms associated with toxic trimethylbenzene exposure include: [1., 2., 3., 5.]
1,2,4-Trimethylbenzene (1,2,4-TMB) exposure is associated with some serious long-term health consequences, particularly respiratory, neurological and hematological effects.
Respiratory Consequences [2., 3.]
1,2,4-TMB exposure has been significantly associated with increased asthma risk in epidemiological studies.
It has also been associated with bronchitis, although confounding from other solvents is possible. [3., 11., 12.]
Hematological Consequences
Anemia has been demonstrated as a consequence of excessive trimethylbenzene exposure. [3., 11., 12.]
Neurological Consequences
Occupational studies link TMB exposure to neurological effects like nervousness and anxiety, though confounding from other solvents is possible. [3., 11., 12.]
Animal studies show neurotoxic effects like decreased pain sensitivity, cognitive/behavioral changes. [3., 11., 12.]
Respiratory, hematological, and organ toxicity have all been demonstrated with subchronic TMB exposure. [3., 11., 12.]
Organic acids are organic compounds with acidic properties. They include a variety of functional groups like carboxyl, phenol, enol, and thiol, with carboxylic acids having the strongest acidity.
Organic acids are considered weak acids, with those containing phenol, enol, alcohol, or thiol groups being even weaker.
Their structures vary in terms of carbon chain types—aromatic, aliphatic, alicyclic, heterocyclic—saturation, substitutions, and the number of functional groups.
These acids play critical roles in metabolic and catabolic pathways, notably in the tricarboxylic acid cycle inside mitochondria, which is central to energy production in eukaryotes. They are also pivotal in determining the sensory properties of fruits and vegetables.
Some organic acids are produced as byproducts of toxin metabolism, and their presence indicates the degree of exposure to parent toxins.
Organic Acid Testing in Functional Medicine
In functional medicine, organic acid testing is utilized to evaluate a patient's metabolic function through a simple urine test. This testing can identify metabolic imbalances that may affect a patient’s mood, energy, and overall health.
Testing provides insights into nutrient deficiencies, dietary habits, toxic exposures, and gut microbiome activity.
The results assist practitioners in customizing treatment plans to address specific metabolic dysfunctions and improve health outcomes.
Additionally, it helps in assessing the impact of microbial metabolism and the efficiency of the Krebs Cycle, aiding in personalized healthcare.
Laboratory testing for organic acids including 3,4-Dimethylhippurate is typically done in urine, although it can also be tested in blood. Testing may be ordered to diagnose an inborn metabolic disorder, or to assess metabolic function and gastrointestinal health in a functional medicine setting.
Urine samples may be collected in a clinical setting; they can also be collected at home. Some labs recommend or require a first morning void sample, to provide a concentrated sample.
Generally, falling within reference ranges for organic acids is recommended, although for many of these organic acids, a level towards the lower end of the reference range is considered optimal.
In the case of 3,4-Dimethylhippurate, which is the metabolite of a known toxin, optimal levels are undetectable.
It is essential to consult with the laboratory company used for their recommended reference range for 3,4-Dimethylhippurate.
One company reports the following reference range for 3,4-Dimethylhippurate: < 0.01 mcg/mg creatinine [9.]
Elevated levels of 3,4-Dimethylhippurate indicate current or recent exposure to 1,2,4-Trimethylbenzene.
Undetectable, or very low, levels of 3,4-Dimethylhippurate are considered optimal.
3,4-Dimethylhippurate is typically tested along with other organic acids to gain deeper insights into metabolic pathways and physiological processes.
Organic acids that may be tested as part of a panel include:
2-Hydroxybutyric Acid: this acid is a marker for insulin resistance and increased oxidative stress.
2-Hydroxyphenylacetic Acid: derived from phenylalanine metabolism, this acid is used as a biomarker in various metabolic assessments.
3-Hydroxybutyric Acid: a ketone body produced during fat metabolism, indicative of carbohydrate deprivation or ketogenic conditions.
3-Hydroxyisovaleric Acid: an organic acid that accumulates in leucine catabolism disorders, often elevated in maple syrup urine disease.
3-Indoleacetic Acid: a metabolite of tryptophan, it is significant in the study of serotonin pathways and plant growth regulation.
4-Hydroxybenzoic Acid: a derivative of tyrosine metabolism, it is linked to catechin (green tea) metabolism and may be produced by some intestinal bacteria.
4-Hydroxyphenylacetic Acid: a breakdown product of tyrosine, used in diagnosing disorders involving the degradation of aromatic amino acids.
5-Hydroxyindoleacetic Acid: the main metabolite of serotonin, used as a marker in the diagnosis of carcinoid syndrome.
Adipic Acid: a dicarboxylic acid that can also be formed metabolically in humans through the oxidation of certain fatty acids.
a-Keto-b-Methylvaleric Acid: an intermediate in isoleucine metabolism, which can accumulate in certain metabolic disorders.
a-Ketoisocaproic Acid: an intermediate in the metabolism of leucine, elevated in maple syrup urine disease.
a-Ketoisovaleric Acid: a breakdown product of valine metabolism, also linked to maple syrup urine disease.
a-Ketoglutaric Acid: a key intermediate in the citric acid cycle, essential for energy production and nitrogen transport.
Benzoic Acid: produced from phenylalanine and polyphenol metabolism by intestinal bacteria. High levels in urine can indicate glycine deficiency or liver dysfunction.
Cis-Aconitic Acid: an intermediate in the tricarboxylic acid cycle, formed by the dehydration of citric acid.
Citric Acid: a central compound in the citric acid cycle, crucial for energy production in cells.
Ethylmalonic Acid: this acid accumulates in ethylmalonic encephalopathy and is involved in fatty acid metabolism.
Fumaric Acid: an intermediate in the tricarboxylic acid (TCA) cycle, participating in energy production through its conversion to malate and subsequent participation in the generation of ATP.
Homovanillic Acid: a major metabolite of dopamine, used as a marker to monitor dopamine levels.
Hippuric Acid: formed from the conjugation of benzoic acid and glycine; elevated levels can indicate exposure to certain environmental toxins.
Hydroxymethylglutarate: an intermediate in leucine metabolism, also associated with disorders of ketogenesis and ketolysis.
Isocitric Acid: an isomer of citric acid and an important part of the citric acid cycle, pivotal in cellular energy production.
Kynurenic Acid: a product of tryptophan metabolism, known for its role as a neuroprotective agent.
Lactic Acid: produced from pyruvate via anaerobic metabolism, an indicator of hypoxia and strenuous exercise.
Malic Acid: a dicarboxylic acid found in fruits, and involved in the citric acid cycle.
Methylmalonic Acid: an indicator of Vitamin B12 deficiency, it accumulates when the vitamin is deficient.
Methylsuccinic Acid: a dicarboxylic acid often involved in alternative pathways of fatty acid metabolism.
Orotic Acid: involved in the metabolism of pyrimidines, abnormalities in its levels can indicate metabolic disorders.
Pyroglutamic Acid: an uncommon amino acid derivative that can accumulate in glutathione synthesis disorders.
Pyruvic Acid: a key intersection in several metabolic pathways; its levels are crucial for assessing cellular respiration and metabolic function.
Quinolinic Acid: a neuroactive metabolite of the kynurenine pathway, elevated levels are associated with neurodegenerative diseases.
Suberic Acid: a dicarboxylic acid that is a biomarker in adipic aciduria, often studied in relation to fatty acid oxidation disorders.
Succinic Acid: a four-carbon dicarboxylic acid that plays a central role in the Krebs cycle, crucial for energy production.
Tricarballylic Acid: an organic acid that can inhibit aconitase in the citric acid cycle and is sometimes associated with glyphosate exposure.
Vanillylmandelic Acid: a metabolite of epinephrine and norepinephrine, used as a marker for neuroblastoma and other catecholamine-secreting tumors.
Click here to compare testing options and order organic acid testing.
[1.] 1,2,4-Trimethylbenzene. ww2.arb.ca.gov. Accessed June 6, 2024. https://ww2.arb.ca.gov/sites/default/files/classic/toxics/tac/factshts1997/124trimt.pdf
[2.] 1,2,4-Trimethylbenzene. Delaware Health and Social Services. Accessed June 6, 2024. https://dhss.delaware.gov/dhss/dph/files/tmb124faq.pdf
[3.] Air Toxics Hot Spots Program Air and Site Assessment and Climate Indicators Branch Trimethylbenzenes Reference Exposure Levels. Accessed June 6, 2024. https://oehha.ca.gov/media/downloads/crnr/tmbreldraft012723.pdf
[4.] Chahardoli A, Jalilian F, Memariani Z, Farzaei MH, Shokoohinia Y. Analysis of organic acids. Recent Advances in Natural Products Analysis. Published online 2020:767-823. doi:https://doi.org/10.1016/b978-0-12-816455-6.00026-3
[5.] Committee on Acute Exposure Guideline Levels; Committee on Toxicology; Board on Environmental Studies and Toxicology; Division on Earth and Life Studies; National Research Council. Acute Exposure Guideline Levels for Selected Airborne Chemicals: Volume 13. Washington (DC): National Academies Press (US); 2012 Dec 28. 8, Trimethylbenzenes. Available from: https://www.ncbi.nlm.nih.gov/books/NBK241481/
[6.] French D. Advances in Clinical Mass Spectrometry. Advances in Clinical Chemistry. 2017;79:153-198. doi:https://doi.org/10.1016/bs.acc.2016.09.003
[7.] Huo JZ, Aldous S, Campbell K, Davies N. Distribution and metabolism of 1,2,4-trimethylbenzene (pseudocumene) in the rat. Xenobiotica. 1989 Feb;19(2):161-70. doi: 10.3109/00498258909034688. PMID: 2728490.
[8.] Ichiba M, Hama H, Yukitake S, Kubota M, Kawasaki S, Tomokuni K. Urinary excretion of 3,4-dimethylhippuric acid in workers exposed to 1,2,4-trimethylbenzene. Int Arch Occup Environ Health. 1992;64(5):325-7. doi: 10.1007/BF00379541. PMID: 1487328.
[9.] Rupa Health. Organic Acids + EPP Combined Test Sample Report.pdf. Google Docs. https://drive.google.com/file/d/19oBp22Y_KRokT2Pm2hF1FcnJQccV0oqt/view
[10.] Toxicological Review of Trimethylbenzenes. US Environmental Protection Agency. Published August 2013. Accessed June 6, 2024. www.epa.gov/iris
[11.] Toxicological Review of Trimethylbenzenes.; 2016. Accessed June 6, 2024. https://iris.epa.gov/static/pdfs/1037tr.pdf